Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 4, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Debra Chew: Lifted Out Of The Quicksand Of Fear

I sat paralyzed in my car at the bottom of a steep driveway - on Signal Mountain.  I had an important lunch meeting there because I was about to be introduced to Dalton Roberts, a writer from Chattanooga.  I had enjoyed reading his columns, and as I was a new writer, not only was I looking forward to gaining some insight into publishing opportunities in Chattanooga but ... (click for more)

Morning Pointe Residents Put Contest Earnings Toward Alzheimer's Fundraiser

Morning Pointe of Chattanooga at Shallowford was the regional winner of the corporate Spring Fling contest.  The assisted community was rewarded with $550 for a celebration.  Instead of having a party, the directors of Morning Pointe of Chattanooga knew that residents would want to share their prize with the community so they decided to put it towards one of their biggest ... (click for more)

Woman Seriously Injured After Plowing Into Rossville Boulevard Car Dealership Saturday Evening

A woman was seriously injured after plowing her vehicle into a car dealership on Rossville Boulevard on Saturday evening.   At approximately  6:49 p.m., the Chattanooga Police Department responded to 2818 Rossville Blvd. on an accident with injuries.   A blue vehicle traveling at a high rate of speed lost control.  The vehicle crashed ... (click for more)

Boy, 4, Struck By Vehicle Near Tunnel Boulevard

A four-year-old boy was struck by a vehicle near Tunnel Boulevard on Saturday afternoon. A t approximately 4:20 p.m.,  the Chattanooga Police Department responded to 3400 Through St. on a c hild struck by a vehicle.  T he victim was conscious when officers arrived. He was transported to a local hospital. I nvestigators are continuing to compile ... (click for more)

DWT Is DUI - And Response

A routine narrative of a DUI arrest report goes something like this:   The defendant was operating a motor vehicle in the 00 block of sonsoroad. The driver was weaving back and forth across the marked roadway. The defendant drove through a stop sign. Was stopped at an intersection despite the traffic light was green. Entered the lane of another vehicle and caused a ... (click for more)

Roy Exum: What Voters Think

There are over 9,000 students who attend Quinnipiac University in Hamden, Conn., which – in an effort to be relative -- is just a touch smaller than our UT-Chattanooga. What makes Quinnipiac unique is that it is home of The Quinnipiac University Polling Institute, which produces what’s called the “Q Poll” because hardly anybody knows how to pronounce “Kwin-uh-pe-ack.” The Q ... (click for more)